Future structural studies and in vivo infection models will be valuable to fully elucidate the physiological relevance of PtpB-MIP’s immunomodulatory activity and to explore its potential applications in managing inflammatory and autoimmune disorders. This evidence concerns the gene PTPRB and autoimmune disease.